Trastuzumab in breast cancer - Reply

被引：0

作者：

Mano, M

Cameron, D

Gelber, RD ^{[1
]}

机构：

[1] Inst Jules Bordet, B-1000 Brussels, Belgium

[2] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：642 / 643

页数：2

共 50 条

[31] Trastuzumab Therapy for Early Breast Cancer
Charbonneau, Flay
CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2006, 59 : 41 - 42
[32] Trastuzumab safe in breast cancer progression?
Reactions Weekly, 2004, 1005 (1) : 4 - 4
[33] Trastuzumab/trastuzumab emtansineDevelopment of resistance in metastatic breast cancer: case report
Reactions Weekly, 2017, 1646 (1) : 318 - 318
[34] Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab - Reply
Pestalozzi, BC
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) : 3298 - 3298
[35] Neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for HER-2-positive operable breast cancer - Reply
Buzdar, AU
Theriault, RL
Hunt, KK
Hortobagyi, GN
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) : 7760 - 7761
[36] Pharmacology and therapeutic use of trastuzumab in breast cancer
Treish, I
Schwartz, R
Lindley, C
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (22) : 2063 - 2076
[37] Identifying responders to trastuzumab therapy in breast cancer
Brugmann, Anja
Sorensen, Boe S.
FUTURE ONCOLOGY, 2011, 7 (06) : 767 - 773
[38] Ongoing adjuvant trials with trastuzumab in breast cancer
Tan, AR
Swain, SM
SEMINARS IN ONCOLOGY, 2003, 30 (05) : 54 - 64
[39] Trastuzumab: updatedmechanisms of action and resistance in breast cancer
Thuy Vu
Claret, Francois X.
FRONTIERS IN ONCOLOGY, 2012, 2 : 1 - 6
[40] Trastuzumab and breast cancer: Developments and current status
Tokunaga E.
Oki E.
Nishida K.
Koga T.
Egashira A.
Morita M.
Kakeji Y.
Maehara Y.
International Journal of Clinical Oncology, 2006, 11 (3) : 199 - 208

← 1 2 3 4 5 →